Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR‐183/&bgr;‐TrCP/SP1 axis‐mediated BAX upregulation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.taap.2017.08.019PMID 28867437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Myeloid Leukemia

  2020cited by this paper
• Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin

  2017cited by this paper
• Tert-butyl hydroperoxide (t-BHP) induced apoptosis and necroptosis in endothelial cells: Roles of NOX4 and mitochondrion

  2017cited by this paper
• Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells

  2016cited by this paper
• Aberrant splicing and drug resistance in AML

  2016cited by this paper
• Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.

  2016cited by this paper
• Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia.

  2016influential reference
• Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade

  2016cited by this paper
• Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.

  2016cited by this paper
• Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review.

  2016cited by this paper
• Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth

  2015cited by this paper
• NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells.

  2015cited by this paper
• How we will treat chronic myeloid leukemia in 2016.

  2015cited by this paper
• Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

  2015influential reference
• Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.

  2015influential reference
• Constitutive Activation of MEK1 Promotes Treg Cell Instability in Vivo*

  2014cited by this paper
• Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?

  2013influential reference
• A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

  2013cited by this paper
• Suppression of Akt/Foxp3-mediated miR-183 expression blocks Sp1-mediated ADAM17 expression and TNFα-mediated NFκB activation in piceatannol-treated human leukemia U937 cells.

  2012influential reference
• Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901.

  2012cited by this paper
• Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity

  2012influential reference
• Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers

  2011influential reference
• The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias

  2011cited by this paper
• Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents

  2011cited by this paper
• Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer

  2011influential reference
• Calcium‐stimulated mitogen‐activated protein kinase activation elicits Bcl‐xL downregulation and Bak upregulation in notexin‐treated human neuroblastoma SK‐N‐SH cells

  2010cited by this paper
• Caffeine induces matrix metalloproteinase‐2 (MMP‐2) and MMP‐9 down‐regulation in human leukemia U937 cells via Ca2+/ROS‐mediated suppression of ERK/c‐fos pathway and activation of p38 MAPK/c‐jun pathway

  2010influential reference
• Quinacrine Enhances Cisplatin-Induced Cytotoxicity in Four Cancer Cell Lines

  2010influential reference
• Reactive oxygen species, cellular redox systems, and apoptosis.

  2010cited by this paper
• Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin

  2010influential reference
• EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells

  2009cited by this paper
• 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways

  2009cited by this paper
• Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications

  2009influential reference
• Cutting Edge: TGF-β-Induced Expression of Foxp3 in T cells Is Mediated through Inactivation of ERK

  2008cited by this paper
• RelA/NF-κB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells

  2008cited by this paper
• P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg

  2008cited by this paper
• Enhanced therapeutic effects on the multi‐drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine

  2008cited by this paper
• Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer

  2007cited by this paper
• STAT1 regulates p73‐mediated Bax gene expression

  2007cited by this paper
• Deregulation of apoptosis in acute myeloid leukemia.

  2007influential reference
• ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

  2007cited by this paper
• Bcl‐2 changes conformation to inhibit Bax oligomerization

  2006cited by this paper
• Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities

  2006cited by this paper
• Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.

  2005cited by this paper
• G125A single-nucleotide polymorphism in the human BAX promoter affects gene expression

  2005cited by this paper
• Acridine derivatives activate p53 and induce tumor cell death through bax

  2005cited by this paper
• Acute myeloid leukemia

  2004cited by this paper
• Pharmacokinetics of quinacrine in the treatment of prion disease

  2004cited by this paper
• Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene

  2002cited by this paper
• Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines

  2001cited by this paper
• Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.

  2001cited by this paper
• The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter*

  2001cited by this paper
• The expanding role of mitochondria in apoptosis.

  2001cited by this paper
• Bax is a transcriptional target and mediator of c-myc-induced apoptosis.

  2000cited by this paper
• High bax expression is a good prognostic indicator in acute myeloid leukaemia

  2000influential reference
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper

• ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.

  2024cites this paper
• AMTAC-19, a Spiro-Acridine Compound, Induces In Vitro Antitumor Effect via the ROS-ERK/JNK Signaling Pathway

  2024cites this paper
• An Overview of Acridine Analogs: Pharmacological Significance and Recent Developments.

  2024cites this paper
• Beta-Transducin Repeats-Containing Proteins as an Anticancer Target

  2023cites this paper
• Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression

  2023cites this paper
• Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.

  2023cites this paper
• BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.

  2023cites this paper
• Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.

  2023cites this paper
• Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone

  2022cites this paper
• Acridine as an Anti-Tumour Agent: A Critical Review

  2022influential citation
• The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role

  2022cites this paper
• BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.

  2022cites this paper
• Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia

  2021cites this paper
• Carboxyl group-modified α-lactalbumin induces TNF-α-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis.

  2021cites this paper
• Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells.

  2020cites this paper
• 3,3'-diindolylmethane exerts antiproliferation and apoptosis induction by TRAF2-p38 axis in gastric cancer.

  2020cites this paper
• Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle.

  2020cites this paper
• Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells

  2019cites this paper
• Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling

  2019cites this paper
• Non‐mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis‐mediated TNF‐&agr; upregulation

  2019cites this paper
• The role of miR-183 cluster in immunity.

  2019cites this paper
• Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.

  2019cites this paper
• Regulation of F-box proteins by noncoding RNAs in human cancers.

  2019cites this paper
• The suppressive effect of arsenic trioxide on TET2‐FOXP3‐Lyn‐Akt axis‐modulated MCL1 expression induces apoptosis in human leukemia cells

  2018cites this paper
• FOXP3 inhibits MYC expression via regulating miR‐198 and influences cell viability, proliferation and cell apoptosis in HepG2

  2018cites this paper
• ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells.

  2018cites this paper